Any clinical benefit from the use of oncofoetal markers in the management of chemotherapy for patients with metastatic colorectal carcinomas?
暂无分享，去创建一个
C. Lombard-Bohas | P. Valette | F. Chapuis | S. Touzet | V. Trillet-lenoir | G. Freyer | O. Glehen | G. Lledo | J. Bleuse | J. Barbier | J. Gaudin | M. Gouttebel | J. Boyer | L. Chassignol | H. Hamon | S. Claudel-Bonvoisin | E. Leprince | P. Amoyal | P. Darnand | M. Heilmann | V. Trillet‐Lenoir | C. Lombard‐Bohas